This activity is expired and is no longer available for CME credit.


Early Experience Using Aflibercept in the Treatment of Wet Macular Degeneration

Author(s)/Faculty: Michael W. Stewart, MD
Release Date: 12/1/2012Expiration Date: 12/1/2013
Credit Type: CMENumber of Credits: 0
Content Type: Provider:
The approval of aflibercept by the US Food and Drug Administration in November 2011, provided retina surgeons with a fourth potent anti-VEGF drug for the treatment of exudative age-related macular degeneration (AMD)...